David Montani: How to Treat Pulmonary Embolism Catheter or Standard Therapy
David Montani, Professor of Universities and Hospital Practitioner (PU-PH) in Pulmonology at Université Paris-Saclay, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Happy to share this article published in Archives of Cardiovascular Diseases: ‘Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study.’
Many thanks to Louis Pot for leading this work and for welcoming a Parisian into a Marseille team.”
Title: Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study
Authors: Louis Pot, Etienne Cassiani-Ingoni, Marc Gainnier, Julien Carvelli, Mohamed Boucekine, Pauline Moyse, Florent Arregle, Octave Cannac, Damien Barrau, Marc Laine, Jennifer Cautela, David Montani, Laurent Bonello
Read the Full Article on Archives of Cardiovascular Diseases
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia